Protocol Ledger

NCT03944512 · Phase III · TERMINATED

Pravastatin to Prevent Preeclampsia

Interventional Phase III clinical trial protocol NCT03944512 sponsored by The George Washington University Biostatistics Center in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-07-17 Enrollment: 102 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03944512
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)102 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03944512
Protocol FieldVerified Registry Value
NCT IdentifierNCT03944512
Consolidated Lead SponsorThe George Washington University Biostatistics Center
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusTERMINATED
Registered Enrollment102 participants (ACTUAL)
Registered Start Date2019-07-17
WhyStopped ClassificationUnspecified

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI